Improving the utilization of implantable cardioverter defibrillators for sudden cardiac arrest prevention (Improve SCA) in developing countries: Clinical characteristics and reasons for implantation refusal

Balbir Singh, Shu Zhang, Chi Keong Ching, Dejia Huang, Yen Bin Liu, Diego A. Rodriguez, Azlan Hussin, Young Hoon Kim, Alexandr Robertovich Chasnoits, Jeffrey Cerkvenik, Katy A. Muckala, Alan Cheng

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Despite available evidence that implantable cardioverter defibrillators (ICDs) reduce all-cause mortality among patients at risk for sudden cardiac death, utilization of ICDs is low especially in developing countries. Objective: To summarize reasons for ICD or cardiac resynchronization therapy defibrillator implant refusal by patients at risk for sudden cardiac arrest (Improve SCA) in developing countries. Methods: Primary prevention (PP) and secondary prevention (SP) patients from countries where ICD use is low were enrolled. PP patients with additional risk factors (syncope, ejection fraction < 25%, nonsustained ventricular tachycardia [NSVT], or frequent premature ventricular complexes) were further categorized as “1.5 PP patients.” Candidates who declined implantation were asked for reasons for refusal. Baseline factors that may have influenced the implant decision were examined using logistic regression. Results: Among 3892 patients, the implant refusal rate was 46.5% among PP patients (n = 2700), and 10.3% among SP patients (n = 1192). The most common refusal reason was inability to pay for the device (53.8%), followed by not believing in the benefits of the ICD (19.4%). Among PP ICD candidates, those with no syncope, no NSVT, no premature ventricular contractions, shorter QRS duration, no atrial arrhythmias, and no left bundle branch block were more likely to refuse implant. Among SP candidates, a history of cardiovascular surgery and no sinus node dysfunction were significant predictors of ICD refusal. Additionally, countries had significant differences in patient refusal rates among PP and SP groups. Conclusion: Implant refusal among PP patients is high in many countries. Increased reimbursement and better awareness of the benefits of an ICD could increase their utilization.

Original languageEnglish
Pages (from-to)1619-1626
Number of pages8
JournalPACE - Pacing and Clinical Electrophysiology
Volume41
Issue number12
DOIs
Publication statusPublished - 2018 Dec 1

Keywords

  • implantable cardioverter defibrillator
  • primary prevention
  • secondary prevention
  • sudden cardiac arrest
  • underutilization

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Improving the utilization of implantable cardioverter defibrillators for sudden cardiac arrest prevention (Improve SCA) in developing countries: Clinical characteristics and reasons for implantation refusal'. Together they form a unique fingerprint.

  • Cite this

    Singh, B., Zhang, S., Ching, C. K., Huang, D., Liu, Y. B., Rodriguez, D. A., Hussin, A., Kim, Y. H., Chasnoits, A. R., Cerkvenik, J., Muckala, K. A., & Cheng, A. (2018). Improving the utilization of implantable cardioverter defibrillators for sudden cardiac arrest prevention (Improve SCA) in developing countries: Clinical characteristics and reasons for implantation refusal. PACE - Pacing and Clinical Electrophysiology, 41(12), 1619-1626. https://doi.org/10.1111/pace.13526